Class 4 Drug Caution in use - MOMETASONE FUROATE 50 MICROGRAM / DOSE NASAL SPRAY, SUSPENSION

PilsCo Ltd. have identified a error relating to the wording on the outer carton label. The label affixed on the bottle states: ‘use within 2 weeks of first use’, instead of the correct label statement which should be: ‘use within 2 months of first use

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-mometasone-furoate-50-microgram-slash-dose-nasal-spray-suspension-pilsco-ltd-el-21-a-slash-33?utm_medium=email&utm_campaign=govuk-notifications&utm_source=e049222e-87bd-466b-af5c-870967570da8&utm_content=immediately    

This is a caution in use only we are not accepting stock returns.

Further Information

For more information, medical information queries or stock control queries, please contact: Nigel Kelly Nigel@ethigen.co.uk 013555 98155

If you have any questions, then please contact your local Service Centre Customer Services team.